S
Salvatore Siena
Researcher at University of Milan
Publications - 572
Citations - 62791
Salvatore Siena is an academic researcher from University of Milan. The author has contributed to research in topics: Colorectal cancer & Panitumumab. The author has an hindex of 91, co-authored 524 publications receiving 53868 citations. Previous affiliations of Salvatore Siena include Novartis & Indiana University.
Papers
More filters
Journal ArticleDOI
7100 High-dose sequential chemotherapy versus conventional-dose chemotherapy as first-line treatment for advanced poor prognosis germ-cell tumors: a multicenter Phase III Italian trial
M. Di Nicola,Andrea Necchi,Nicola Nicolai,Carmelo Bengala,Salvatore Siena,A. Novarino,Carmelo Carlo-Stella,Luigi Piva,A. M. Gianni,Roberto Salvioni +9 more
Journal ArticleDOI
Eucharistic problems for celiac patients.
Journal ArticleDOI
Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia.
TL;DR: The role of iron supplementation in the setting of CRA is discussed in view of recent reports that have addressed this issue, and iron supplementation has not been pursued as rigorously in anemic patients with cancer as it has in patients with chronic kidney disease.
Journal ArticleDOI
Analyses of updated overall survival (OS) and prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and CA 19-9 from the phase III MPACT study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem for patients (pts) with metastatic pancreatic cancer (PC).
David Goldstein,Robert Hassan El-Maraghi,Pascal Hammel,Volker Heinemann,Volker Kunzmann,Javier Sastre,Werner Scheithauer,Salvatore Siena,Teresa Macarulla,Luis Augusto Teixeira,Giampaolo Tortora,Jean-Luc Van Laethem,Darryl Penenberg,Brian Lu,Alfredo Romano,Daniel D. Von Hoff +15 more
TL;DR: An updated OS analysis (post hoc) and an assessment of pts with elevated NLR or elevated CA 19-9 at baseline, 2 accepted markers of poor prognosis are reported.
Journal ArticleDOI
Combined negative and positive selection of mobilized CD34 blood cells.
Massimo Di Nicola,M. Bregni,Salvatore Siena,P. A. Ruffini,Marco Milanesi,Fernando Ravagnani,A. Massimo Gianni +6 more
TL;DR: In this paper, the authors tested four negative and two positive selection methods for separation of CD34 + cells from mobilized blood cells, and analyzed fold-enrichment, purity and recovery of cells after selection procedures.